Healthcare Industry News Weekly Wrap-Up: October 28, 2022
// Biotech and Pharma Therapeutics For Biogen investors, company’s outlook rests on next Alzheimer’s drug October 25, 2022 / Alzheimer’s / Investors / Biogen Biogen, in what’s become a pattern over the past two years, spent much of its latest...